共 50 条
- [3] MCT4 Defines a Glycolytic Subtype of Pancreatic Cancer with Poor Prognosis and Unique Metabolic Dependencies CELL REPORTS, 2014, 9 (06): : 2233 - 2249
- [4] MCT4 as a potential therapeutic target to augment gemcitabine chemosensitivity in resected pancreatic cancer Cellular Oncology, 2021, 44 : 1363 - 1371